NO303287B1 - DNA, DNA-fragment, rekombinant DNA, DNA-hybridisasjonsprobe, vertscelle, rekombinant peptid og immunogen sammensetning - Google Patents
DNA, DNA-fragment, rekombinant DNA, DNA-hybridisasjonsprobe, vertscelle, rekombinant peptid og immunogen sammensetning Download PDFInfo
- Publication number
- NO303287B1 NO303287B1 NO874750A NO874750A NO303287B1 NO 303287 B1 NO303287 B1 NO 303287B1 NO 874750 A NO874750 A NO 874750A NO 874750 A NO874750 A NO 874750A NO 303287 B1 NO303287 B1 NO 303287B1
- Authority
- NO
- Norway
- Prior art keywords
- dna
- hpv
- nucleotide
- fragment
- recombinant
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title claims abstract description 34
- 239000000523 sample Substances 0.000 title claims abstract description 18
- 108020004414 DNA Proteins 0.000 title claims description 52
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 18
- 238000009396 hybridization Methods 0.000 title claims description 15
- 108020004511 Recombinant DNA Proteins 0.000 title claims description 11
- 239000000203 mixture Substances 0.000 title claims description 5
- 230000002163 immunogen Effects 0.000 title claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 33
- 239000002773 nucleotide Substances 0.000 claims abstract description 32
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108700026244 Open Reading Frames Proteins 0.000 claims description 11
- 239000013598 vector Substances 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 108020005202 Viral DNA Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 40
- 241001631646 Papillomaviridae Species 0.000 description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 241000341655 Human papillomavirus type 16 Species 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- 108091092724 Noncoding DNA Proteins 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 229920001184 polypeptide Polymers 0.000 description 11
- 239000003623 enhancer Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 241000701806 Human papillomavirus Species 0.000 description 8
- 241000388186 Deltapapillomavirus 4 Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000008488 polyadenylation Effects 0.000 description 5
- 108091027569 Z-DNA Proteins 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 208000019065 cervical carcinoma Diseases 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 206010059313 Anogenital warts Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004638 Circular DNA Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 208000000907 Condylomata Acuminata Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 231100000590 oncogenic Toxicity 0.000 description 2
- 230000002246 oncogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 241000537222 Betabaculovirus Species 0.000 description 1
- 241000701822 Bovine papillomavirus Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 241000829111 Human polyomavirus 1 Species 0.000 description 1
- 101710125507 Integrase/recombinase Proteins 0.000 description 1
- 241000701646 Kappapapillomavirus 2 Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000713862 Moloney murine sarcoma virus Species 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
- 201000004201 anogenital venereal wart Diseases 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 230000006490 viral transcription Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP86400609 | 1986-03-21 | ||
| PCT/EP1987/000158 WO1987005630A1 (fr) | 1986-03-21 | 1987-03-20 | Sequences d'adn determinees derivees d'un genome du virus du papillome, utilisation desdites sequences pour des diagnostiques in vitro et production de compositions antigenes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO874750D0 NO874750D0 (no) | 1987-11-13 |
| NO874750L NO874750L (no) | 1987-11-13 |
| NO303287B1 true NO303287B1 (no) | 1998-06-22 |
Family
ID=8196291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO874750A NO303287B1 (no) | 1986-03-21 | 1987-11-13 | DNA, DNA-fragment, rekombinant DNA, DNA-hybridisasjonsprobe, vertscelle, rekombinant peptid og immunogen sammensetning |
Country Status (13)
| Country | Link |
|---|---|
| US (7) | US5554538A (fr) |
| EP (1) | EP0243221B1 (fr) |
| JP (2) | JP2633275B2 (fr) |
| KR (1) | KR930007580B1 (fr) |
| AT (1) | ATE76429T1 (fr) |
| AU (1) | AU615159B2 (fr) |
| DE (1) | DE3779175D1 (fr) |
| DK (1) | DK175314B1 (fr) |
| ES (1) | ES2039254T3 (fr) |
| FI (1) | FI100057B (fr) |
| GR (1) | GR3005272T3 (fr) |
| NO (1) | NO303287B1 (fr) |
| WO (1) | WO1987005630A1 (fr) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5876922A (en) | 1985-07-31 | 1999-03-02 | Institute Pasteur | Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections |
| KR930007580B1 (ko) * | 1986-03-21 | 1993-08-13 | 엥스띠뛰 빠스뙤르 | 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 |
| US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
| FR2629458B2 (fr) * | 1987-07-31 | 1991-08-09 | Ire Celltarg Sa | Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain |
| JPH03503605A (ja) * | 1988-04-04 | 1991-08-15 | オンカー インコーポレーテッド | ヒトパピローマウイルス分類法および該方法に使用する核酸プローブ |
| FR2632956B2 (fr) * | 1988-05-13 | 1991-07-12 | Pasteur Institut | Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus |
| FR2631341B1 (fr) * | 1988-05-13 | 1991-04-26 | Pasteur Institut | Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55 et produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55 et procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus |
| CA1339729C (fr) * | 1988-10-26 | 1998-03-17 | Wayne D. Lancaster | Sequences d'and pour virus des papillomes humains de type 52 methode d'utilisation |
| SE8803870D0 (sv) * | 1988-10-28 | 1988-10-28 | Medscand Ab | Method for detection of human papillomavirus (hpv) for diagnostic purposes |
| DE3838269A1 (de) * | 1988-11-11 | 1990-05-17 | Behringwerke Ag | Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen |
| JPH05501650A (ja) * | 1989-12-01 | 1993-04-02 | バイシス・インコーポレーテツド | Ｈｐｖ転写物の検出 |
| US5580970A (en) * | 1989-12-01 | 1996-12-03 | Amoco Corporation | Detection of HPV transcripts |
| FR2656627B1 (fr) * | 1989-12-28 | 1992-04-17 | Pasteur Institut | Sonde a papillomavirus (hvpv63), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus. |
| SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
| US5932412A (en) * | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
| CA2052413C (fr) * | 1990-09-28 | 2004-07-13 | Jeffrey L. Joseph | Sequence de nucleotides utiles comme sondes specifiques, amorces de la rcp et sondes de la rcl pour l'amplification et la detection du virus du papillome humain, et trousses et methodes connexes |
| US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
| US6183746B1 (en) * | 1997-10-09 | 2001-02-06 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
| US7569344B2 (en) * | 1998-10-26 | 2009-08-04 | Ventana Medical Systems, Inc. | Detection of human papilloma virus in papanicolaou (Pap) smears |
| WO2000061804A1 (fr) * | 1999-04-14 | 2000-10-19 | Musc Foundation For Research Development | Agents toxiques et ribozymes specifiques de tissu et specifiques de pathogene |
| US20050100928A1 (en) * | 1999-09-16 | 2005-05-12 | Zycos Inc., A Delaware Corporation | Nucleic acids encoding polyepitope polypeptides |
| US20060275784A1 (en) * | 1999-10-26 | 2006-12-07 | Ventana Medical Systems, Inc. | Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears |
| AU2001256976A1 (en) * | 2000-04-03 | 2001-10-15 | Cytyc Corporation | Detection and typing of human papillomavirus using pna probes |
| US6936443B2 (en) * | 2000-04-03 | 2005-08-30 | Cytyc Corporation | Detection and typing of human papillomavirus using PNA probes |
| US20040229298A1 (en) * | 2000-11-11 | 2004-11-18 | Lu Peter S. | Methods and compositions for treating cervical cancer |
| US7312041B2 (en) * | 2001-02-16 | 2007-12-25 | Arbor Vita Corporation | Methods of diagnosing cervical cancer |
| US20030059806A1 (en) * | 2001-01-05 | 2003-03-27 | Science & Technology Corporation @ Unm | Probes for the detection of human papillomavirus |
| NZ533703A (en) | 2002-01-07 | 2006-05-26 | Norchip As | Method for detecting human papillomavirus mRNA |
| HUP0200981A3 (en) | 2002-03-14 | 2004-06-28 | Genoid Kft | Pcr reactions with hybridizing probes using primers with broad genotype-specificity for detection of human papilloma-viruses and typing amplificates by using specifically hybridizing oligonucleotides |
| JP2005537028A (ja) * | 2002-06-26 | 2005-12-08 | ザ ペン ステート リサーチ ファウンデーション | ヒト乳頭腫ウイルス感染症を治療する方法及び材料 |
| EP1537415B1 (fr) | 2002-09-09 | 2008-12-17 | Arbor Vita Corporation | Procede de diagnostic du cancer du col de l'uterus |
| US20060247190A1 (en) * | 2002-10-21 | 2006-11-02 | Kathleen Beach | Compositions and methods for treating human papillomavirus mediated disease |
| EP1664348B8 (fr) | 2003-09-25 | 2019-06-12 | Third Wave Technologies, Inc. | Detection de papillomavirus |
| AU2004308964B2 (en) * | 2003-12-23 | 2010-09-16 | Arbor Vita Corporation | Antibodies for oncogenic strains of HPV and methods of their use |
| ATE476528T1 (de) | 2004-12-08 | 2010-08-15 | Gen Probe Inc | Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus |
| NZ554229A (en) * | 2004-12-10 | 2009-03-31 | Genera Biosystems Pty Ltd | Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS) |
| JP5224821B2 (ja) | 2005-02-01 | 2013-07-03 | アメリカ合衆国 | 広範に交差中和する抗体を誘導するためのパピローマウイルスｌ２ｎ末端ペプチド |
| US20070031826A1 (en) * | 2005-08-05 | 2007-02-08 | My Gene | Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof |
| US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
| US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
| US8080643B2 (en) * | 2006-09-05 | 2011-12-20 | Third Wave Technologies, Inc. | HPV primers |
| US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
| WO2010129821A1 (fr) | 2009-05-07 | 2010-11-11 | Oncohealth Corporation | Identification de grade élevée ou ≥cin2 pour détection, surveillance et diagnostic, à des stades précoces et des stades avancés, de papillomavirus humain (hpv) et de cancers associés au hpv |
| US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
| WO2008124091A2 (fr) * | 2007-04-05 | 2008-10-16 | Genera Biosystems Limited | Compositions et procédés de détection |
| US8980562B1 (en) | 2007-06-12 | 2015-03-17 | Physicians Reference Laboratory | Method of simultaneous detection and typing of human papilloma viruses |
| WO2011084598A1 (fr) | 2010-01-08 | 2011-07-14 | Oncohealth Corporation | Immunoessais sur le vph à base de cellule et à haut débit pour diagnostiquer et dépister des cancers associés au vph |
| BR112012018545A2 (pt) | 2010-01-29 | 2016-05-03 | Qiagen Gaithersburg Inc | método de determinação e confirmação da presença de um hpv em uma amostra |
| AU2011258501B2 (en) | 2010-05-25 | 2016-07-07 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically-truncated probes |
| CN102229660B (zh) * | 2011-05-25 | 2015-04-22 | 厦门大学 | 截短的人乳头瘤病毒33型l1蛋白 |
| CN104076150A (zh) * | 2013-03-28 | 2014-10-01 | 沈萍萍 | 一种hpv-e6蛋白的检测方法 |
| US9936943B1 (en) | 2014-08-07 | 2018-04-10 | Nicholas MANCINI | Suture passing surgical device with atraumatic grasper preventing accidental perforations |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
| US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| FR2524487B1 (fr) * | 1982-04-05 | 1985-11-22 | Pasteur Institut | Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants |
| US4748109A (en) * | 1983-07-01 | 1988-05-31 | Baird Phillip J | Assay method and reagent to determine antibodies to papillomavirus virions |
| US5411857A (en) * | 1985-07-31 | 1995-05-02 | Institut Nationale De La Sante | Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections |
| CA1276575C (fr) * | 1984-11-30 | 1990-11-20 | Sylvie Beaudenon | Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus |
| WO1986005816A1 (fr) * | 1985-04-04 | 1986-10-09 | Georgetown University | Sequences adn et peptides specifiques au virus du papillome |
| FR2586428B1 (fr) * | 1985-08-26 | 1988-11-25 | Pasteur Institut | Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus |
| KR930007580B1 (ko) * | 1986-03-21 | 1993-08-13 | 엥스띠뛰 빠스뙤르 | 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 |
| US4849322A (en) * | 1986-04-30 | 1989-07-18 | E. I. Du Pont De Nemours And Company | Positive-working color proofing film and process |
| DE3625257A1 (de) * | 1986-07-23 | 1988-02-04 | Behringwerke Ag | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika |
| US4849332A (en) * | 1987-05-26 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same |
| US4849331A (en) * | 1987-06-09 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same |
| US4849334A (en) * | 1987-06-09 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same |
| DE3722967A1 (de) * | 1987-07-11 | 1989-01-19 | Behringwerke Ag | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung |
| FR2629458B2 (fr) * | 1987-07-31 | 1991-08-09 | Ire Celltarg Sa | Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain |
| US5182377A (en) * | 1988-09-09 | 1993-01-26 | Hoffmann-La Roche Inc. | Probes for detection of human papillomavirus |
| DE3935592A1 (de) * | 1989-10-26 | 1991-05-02 | Hella Kg Hueck & Co | Verfahren und einrichtung zur regelung der innenraumtemperatur von kraftfahrzeugen |
| JPH05501650A (ja) * | 1989-12-01 | 1993-04-02 | バイシス・インコーポレーテツド | Ｈｐｖ転写物の検出 |
| FR2663040B1 (fr) * | 1990-06-11 | 1995-09-15 | Bio Merieux | Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich. |
| CA2052413C (fr) * | 1990-09-28 | 2004-07-13 | Jeffrey L. Joseph | Sequence de nucleotides utiles comme sondes specifiques, amorces de la rcp et sondes de la rcl pour l'amplification et la detection du virus du papillome humain, et trousses et methodes connexes |
| IT1244462B (it) * | 1990-12-06 | 1994-07-15 | Sclavo Spa | Oligonucleotidi sintetici utili per la diagnosi di infezione da tipi diversi di virus del gruppo papilloma e loro utilizzazione |
-
1987
- 1987-03-20 KR KR1019870701075A patent/KR930007580B1/ko not_active IP Right Cessation
- 1987-03-20 DE DE8787400635T patent/DE3779175D1/de not_active Expired - Lifetime
- 1987-03-20 WO PCT/EP1987/000158 patent/WO1987005630A1/fr active IP Right Grant
- 1987-03-20 AU AU72007/87A patent/AU615159B2/en not_active Expired
- 1987-03-20 AT AT87400635T patent/ATE76429T1/de not_active IP Right Cessation
- 1987-03-20 JP JP62501988A patent/JP2633275B2/ja not_active Expired - Lifetime
- 1987-03-20 ES ES87400635T patent/ES2039254T3/es not_active Expired - Lifetime
- 1987-03-20 EP EP87400635A patent/EP0243221B1/fr not_active Expired - Lifetime
- 1987-11-13 NO NO874750A patent/NO303287B1/no unknown
- 1987-11-17 FI FI875082A patent/FI100057B/fi not_active IP Right Cessation
- 1987-11-18 DK DK198706059A patent/DK175314B1/da not_active IP Right Cessation
-
1992
- 1992-07-28 GR GR920401601T patent/GR3005272T3/el unknown
-
1994
- 1994-03-25 US US08/222,569 patent/US5554538A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/466,711 patent/US5648459A/en not_active Expired - Lifetime
-
1996
- 1996-10-16 JP JP8273824A patent/JP2735537B2/ja not_active Expired - Lifetime
-
1997
- 1997-07-15 US US08/891,801 patent/US5876723A/en not_active Expired - Lifetime
-
1999
- 1999-06-11 US US09/330,076 patent/US6107086A/en not_active Expired - Fee Related
-
2000
- 2000-05-25 US US09/577,493 patent/US6242250B1/en not_active Expired - Fee Related
-
2001
- 2001-04-12 US US09/832,852 patent/US6344314B2/en not_active Expired - Fee Related
-
2003
- 2003-10-22 US US10/691,776 patent/US7063963B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2735537B2 (ja) | 1998-04-02 |
| ATE76429T1 (de) | 1992-06-15 |
| FI875082A0 (fi) | 1987-11-17 |
| US5876723A (en) | 1999-03-02 |
| DK605987A (da) | 1987-11-18 |
| DE3779175D1 (de) | 1992-06-25 |
| FI875082A (fi) | 1987-11-17 |
| JPS63502798A (ja) | 1988-10-20 |
| US6344314B2 (en) | 2002-02-05 |
| US7063963B2 (en) | 2006-06-20 |
| US6107086A (en) | 2000-08-22 |
| GR3005272T3 (fr) | 1993-05-24 |
| DK175314B1 (da) | 2004-08-16 |
| NO874750D0 (no) | 1987-11-13 |
| ES2039254T3 (es) | 1995-04-01 |
| US20040132012A1 (en) | 2004-07-08 |
| DK605987D0 (da) | 1987-11-18 |
| NO874750L (no) | 1987-11-13 |
| FI100057B (fi) | 1997-09-15 |
| EP0243221A1 (fr) | 1987-10-28 |
| US6242250B1 (en) | 2001-06-05 |
| WO1987005630A1 (fr) | 1987-09-24 |
| US5554538A (en) | 1996-09-10 |
| US5648459A (en) | 1997-07-15 |
| AU7200787A (en) | 1987-10-09 |
| JP2633275B2 (ja) | 1997-07-23 |
| US20010049137A1 (en) | 2001-12-06 |
| KR930007580B1 (ko) | 1993-08-13 |
| JPH09117294A (ja) | 1997-05-06 |
| AU615159B2 (en) | 1991-09-26 |
| EP0243221B1 (fr) | 1992-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO303287B1 (no) | DNA, DNA-fragment, rekombinant DNA, DNA-hybridisasjonsprobe, vertscelle, rekombinant peptid og immunogen sammensetning | |
| Cole et al. | Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer | |
| Seif et al. | The genome of human papovavirus BKV | |
| JP4912885B2 (ja) | 酵母におけるｈｐｖ５８ｌ１の最適化発現 | |
| Zhou et al. | Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence | |
| KR101165278B1 (ko) | 효모에서의 ｈｐｖ 45 ｌ1의 최적화된 발현 | |
| JP3207389B2 (ja) | 乳頭腫ウィルス及びその診断方法 | |
| Loeber et al. | Temperature-sensitive mutants identify crucial structural regions of simian virus 40 large T antigen | |
| EP1140974B1 (fr) | Dosage neutralisant utilisant des particules veriformes du papillomavirus humain | |
| Bollag et al. | Purified JC virus T antigen derived from insect cells preferentially interacts with binding site II of the viral core origin under replication conditions | |
| Kondo et al. | Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions | |
| CA1341329C (fr) | Sequences d'adn determinees provenant du genome du papillomavirus, ainsi que leur usage a des fins diagnostiques in vitro ou pour la synthese de compositions antigeniques | |
| EP0942986A1 (fr) | Systemes pour determiner des substances actives contre des maladies associees au vph | |
| Becker et al. | Papovaviruses | |
| ZHOU et al. | L2 N-Terminal Sequence |